This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Bronchial Asthma
and you are
between 12 and 70
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The aim of the trial is to investigate asthma control with 160 to 640 mcg ciclesonide/day. Asthma control will be assessed by the Asthma Control Questionnaire (ACQ).

Provided treatments

  • Drug: Ciclesonide

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01455194. The sponsor of the trial is AstraZeneca and it is looking for 520 volunteers for the current phase.
Official trial title:
Control of Moderate or Severe Asthma With 160, 320 and 640 mcg Ciclesonide/Day. A One-year Randomised, Double-blind, Multicenter Trial.